Practicalities of glutathione supplementation in nutritional support

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 5, Issue 3, 2002, Pages 321-326

  Valencia, Erick ^a   Hardy, Gil ^a  

^a OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMINO ACID; ANTIOXIDANT; GLUTATHIONE; PLACEBO; PROLETE; TAD; VITAMIN;

ANTIOXIDANT ACTIVITY; DIET SUPPLEMENTATION; DRUG MONITORING; HUMAN; NEBULIZER; NONHUMAN; NUTRITIONAL SUPPORT; REVIEW; SEPTIC SHOCK; CRITICAL ILLNESS; METHODOLOGY;

ANTIOXIDANTS; CRITICAL ILLNESS; GLUTATHIONE; HUMANS; NUTRITIONAL SUPPORT;

EID: 0036582615     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200205000-00013     Document Type: Review

References (39)

1. Orsi A, Beltran B, Clementi E, et al. Continuous exposure to high concentrations of nitric oxide leads to persistent inhibition of oxygen consumption by J774 cells as well as extraction of oxygen by the extracellular medium. Biochem J 2000; 346:407-417.
2. Kunz WS. Control of oxidative phosphorylation in skeletal muscle. Biochim Biophys Acta 2001; 1504:12-19.
3. Cadenas E, Davies KJA. Mitochondrial free radical generation, oxidative stress, and aging. Free Rad Biol Med 2000; 29(3/4);222-230.
4. Renehan AG, Booth C, Potten CS. What is apoptosis, and why is it important? Br Med J 2001; 322:1536-1540.
5. Chung C-S, Chaundry HI, Ayala A. The apoptotic response of the lymphoid immune system to trauma, shock, and sepsis. In: Vincet JL, editor. Yearbook of Intensive Care and Emergency Medicine. Springer-Verlag: Berlin, Heidelberg. Germany; 2000:27-40.
6. Valencia E, Hardy G. Glutathione, Nitric oxide and sepsis. Br J Intens Care 2000; 10(5):167-175. This paper outlines an interesting theory about how glutathione defends the body against oxidation under sepsis.
7. Liaudet L, Soriano FG, Szabo C. Poly (ADP-ribose) synthetase as a novel therapeutic target for circulatory shock. In: Vincet JL, editor. Yearbook of Intensive Care and Emergency Medicine. Springer-Verlag: Berlin, Heidelberg. Germany; 2001: 78-89.
8. Lyon J, Rauh-Pfeiffer A, Ming-Yu Y, et al. Cysteine metabolism and whole blood glutathione synthesis in septic paediatric patients. Crit Care Med 2001; 29(4):870-7. An original paper about glutathione synthesis in septic patients that helps to understand how GSH can be used as a drug.
9. Hotchkiss RS, Schmieg RE, Swanson PE, et al. Rapid onset of intestinal epithelial and lymphocyte apoptotic cell death in patients with trauma and shock. Crit Care Med 2000; 28(a):3207-3217.
10. Dennis Lo YM, Rainer TH, Chan LYS, et al. Plasma DNA as a prognostic Marker in trauma patients. Clin Chem 2000; 46(3):319-323.
11. Isner JM. Tissue responses to ischemia: local and remote responses for preserving perfusion of ischemic muscle. J. Clin Invest 2000; 106(5):615-619.
12. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001; 53(1):135-159. An excellent review about how new antioxidant therapy works in the cell.
13. Beltran B, Orsi A, Clementi E, Moncada S. Oxidative stress and S-nitrosylation of proteins in cells. Br J Pharmacol 2000; 129:953-960.
14. Dean RT, Shanlin FU, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 1997; 324:1-18.
15. Ortolani O, Conti A, Raffaele de GA, et al. The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. Am J Respir Crit Care Med 2000; 161:1907-1911. This paper outlines an innovative approach to use GSH as a drug on intensive care patients.
16. Stabler SP, Morton RL, Winski SL, Allen RH, White CW. Effects of parenteral cysteine and glutathione feeding in a baboon model of severe prematurity. Am J Clin Nutr 2000; 72(6):1548-1557.
17. Loguercio C, Piscopo P, Guerriero C, et al. Effect of alcohol abuse and glutathione administration on the circulating levels of glutathione and on antipyrine metabolism in patients with alcoholic liver cirrhosis. Scand J Clin Lab Invest 1996; 56:441-447.
18. Valencia E, Marin A, Hardy G. Glutathione-nutritional and pharmacologie viewpoints: Part IV. Nutrition 2001; 17:783-784. This is a comprehensive review of GSH in foods and its gastrointestinal absorption.
19. Hagen TM, Wierzbicka TG, Sillau AH, et al. Fate of dietary glutathione: disposition in the gastrointestinal tract. Am J Physiol 1990; 259:G524-G529.
20. Favilli F, Marraccini P, Lantomasis T, Vincenzini MT. Effect of orally administered glutathione on glutathione levels in some organs of rats: role of specific transporters. Br J Nutr 1997; 78:293-300.
21. Witschi A, Reddy S, Stofer B, Lauterburg BH. The systemic availability of oral glutathione. Eur J Clin Pharmacol 1992; 43(6):667-669.
22. Hunjan MK, Evered DF. Absorption of glutathione from the gastrointestinal tract. Biochim Biophys Acta 1985; 815:184-188.
23. Roum JH, Borok Z, McElvaney NG, et al. Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis. J Appl Physiol 1999; 87(1):438-443.
24. Lamson DW, Brignall MS. The use of nebulized glutathione in the treatment of emphysema: a case report. Altern Med Rev 2000; 5(5):429-431. Interesting case report using glutathione to correct a clinical problem: (COPD).
25. Testa B, Testa D, Mesolella M, et al. Management of chronic otitis media with effusion: the role of glutathione. Laryngoscope 2001; 111:1436-1489. Excellent study describing nasal aerosol administration of glutathione as a nonsurgical treatment for chronic otitis media with effusion in children.
26. Kugiyama K, Miyao Y, Sakamoto K, et al. Glutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina. Am J Physiol Heart Circ Physiol 2001; 280(1):H264-71.
27. Nakamura M, Thourani VH, Ronson RS, et al. Glutathione reverses endothelial damage from peroxynitrite, the byoproduct of nitric oxide degradation, in crystalloid cardioplegia. Circulation 2000; 102(19 Suppl 3):III332-8. This is an interesting discussion, on the basis of a brief report, of the therapeutic option, of glutathione supplementation for patients undergoing cardiac surgery.
28. Chen TS, Richie JP, Nagasawa HT, Lang CA. Glutathione monoethyl ester protects against glutathione deficiencies due to aging and acetaminophen in mice. Mech Ageing Dev 2000; 120(1-3):127-139.
29. Martina V, Bruno GA, Zumpano E, et al. Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1. J Endocrinol Invest 2001; 24(1):37-41. This is an interesting new approach to use glutathione as a drug for chronic diabetics.
30. Bianchi G, Bugianesi E, Ronchi M, et al. Glutathione kinetics in normal man and in patients with liver cirrhosis. J Hepatol 1997; 26:606-613.
31. Valencia E, Marin A, Hardy G. Glutathione-nutritional and pharmacological viewpoints: part V. Nutrition. 2001; 17:978.
32. Robinson MK, Ahn MS, Rounds JD, et al. Parenteral glutathione monoester enhances tissue antioxidant stores. J Parent Ent Nutr 1992; 16(5):413-418.
33. Usberti M, Lima G, Arisi M, et al. Effect of exogenous reduced glutathione on the survival of red blood cells in hemodialyzed patients. J Nephrol 1997; 10(5):261-265.
34. Sastre J, Sasensi M, Gasco E, et al. Exhaustive physical exercise causes oxidation of glutathione status in blood: prevention by antioxidant administration. Am J Physiol 1992; 263(32):R992-R995.
35. Buhl R, Vogelmeier C, Critenden M, et al. Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol. Proc Natl Acad Sci USA 1990; 87:4063-4067.
36. Gutteridge JMC, Mitchell J. Redox imbalance in critically ill. Br Med Bull 1999; 55(1):49-75.
37. Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 1992; 119(6):598-620.
38. Valencia E, Marin A, Hardy G. Stability of reduced glutathione in parenteral nutrition mixtures with or without glutamine. Proc Nutr Soc 2001; 60:120A. This is the only report in the literature about glutathione stability in TPN mixtures.
39. Bhatia J, Moslen MT, Kaphalia L, Rassin DK. Glutathione and tissue amino acid responses to light-exposed parenteral nutrients. Toxicol Lett 1992; 63:79-89.